Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Corticosteroids on the Human Hippocampus in Depression and Healthy Controls
NCT03896659Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrocortisone (4 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Hippocampal Subfield Activation (Left Hemisphere) at 3 days, Hippocampal Subfield Activation (Right Hemisphere) at 3 days and 2 more. Started Oct 2019; status: completed.
02
Drugs
hydrocortisone
Beyond the preview
Go deeper on NCT03896659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03896659.